UnitedHealth Group Incorporated (UNH)
Senate report says UnitedHealth used aggressive tactics to boost medicare payments, WSJ reports
Health insurer UnitedHealth Group used aggressive tactics to gather diagnoses that can boost Medicare Advantage payments, the Wall Street Journal reported on Monday, citing a U.S. Senate committee investigating the company's practices.
UnitedHealth Group deployed aggressive tactics to collect payment-boosting diagnoses for its Medicare Advantage members, a Senate committee investigating the company's practices said
Sen. Chuck Grassley launched an investigation last year following Wall Street Journal reports examining the company's Medicare Advantage practices.
This ETF Is Proof That the Healthcare Rebound Is Real
With well-publicized losses for companies including UnitedHealth Group NYSE: UNH, Elevance Health NYSE: ELV, and Wegovy and Ozempic maker Novo Nordisk NYSE: NVO, the healthcare sector failed to outperform the broad market last year.
How Corporate Security Has Changed a Year After UnitedHealth Killing
Spending on executive protection is up, and it isn't all bodyguards and trained drivers.
UnitedHealth Sinks 34.5% in a Year: Buy the Dip Before Q4 Earnings?
UNH shares are down 34.5% in a year as costs and margins bite, with Q4 earnings and 2026 guidance set to test whether value is emerging.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
In the most recent trading session, UnitedHealth Group (UNH) closed at $336.4, indicating a +1.91% shift from the previous trading day.
Chart Master: UnitedHealthcare might be setting up for a bearish-to-bullish reversal
Carter Worth, Worth Charting, joins 'Fast Money' to talk what's ahead for UnitedHealthcare.
UnitedHealth has regulatory headwinds to get through in 2026, says DCLA's Sarat Sethi
Sarat Sethi, DCLA, joins 'Closing Bell Overtime' to talk stocks that are struggling heading into 2026 including UnitedHeath, SalesForce, and Amazon.
UNH vs. ELV: Which Managed Care Stock Has the Edge Today?
Elevance Health is edging past UnitedHealth as Carelon's growth, strategic exits and a cheaper valuation shape a stronger near-term setup.
3 Risks That Can Make UnitedHealth Stock Unattractive
UnitedHealth (UNH) has encountered difficulties in the past. Its stock has decreased by over 30% within less than two months on two separate occasions in recent years, erasing billions in market capitalization and nullifying significant gains in a single downturn.
UnitedHealth: An Undervalued Blue-Chip Stock With Multiple Levers To Pull And Ways To Win
UnitedHealth, a managed healthcare firm that provides health insurance, pharmacy benefit management, and care delivery to millions of clients, is now a $297 billion (by market cap) healthcare behemoth. UNH ended last fiscal year with more than $75 billion in cash, cash equivalents, available-for-sale debt securities, and equity securities balances. The company increased its dividend for 16 consecutive years, with a 10-year dividend growth rate of 19.3%.
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
In the latest trading session, UnitedHealth Group (UNH) closed at $331.83, marking a +1.3% move from the previous day.
